Clinical Trials Browser

Phase 2 × Adenocarcinoma × Pemetrexed × Clear all

NCT03664024 2024-08-22

KEYNOTE-782

Phase 2 Completed

118 enrolled 14 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT02498860 2021-08-06

APICAL

Phase 2 Completed

Adenocarcinoma, Lung Neoplasms

NCT02951637 2016-11-01

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Phase 2 Unknown

Adenocarcinoma of Lung, Adenocarcinoma

NCT00940069 2016-02-22

TPEIAL

Phase 2 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01565538 2014-09-15

Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma

Phase 2 Completed

123 enrolled 9 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00191503 2007-01-26

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Phase 2 Completed

Adenocarcinoma